Inhibition of human erythroid colony‐forming units by interleukin‐1 is mediated by gamma interferon
- 1 January 1992
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 150 (1) , 59-64
- https://doi.org/10.1002/jcp.1041500109
Abstract
IL-1 inhibits erythropoiesis in vivo and in vitro. This inhibition was studied by comparing the effect of recombinant human IL-1 (rhIL-1) on highly purified CFU-erythroid (E) generated from peripheral blood burst-forming units-erythroid (BFU-E) (mean purity 44.4%) with its effect on unpurified marrow CFU-E (mean purity 0.36%). Colony formation by marrow CFU-E was significantly inhibited by rhIL-1, while colony formation by highly purified CFU-E was not inhibited. However, purified CFU-E colonies were inhibited by rhIL-1 in the presence of autologous T-lymphocytes, and also by cell-free conditioned medium prepared from T-lymphocytes stimulated by rhIL-1. This inhibitory effect was ablated by neutralizing antibodies to γinterferon (IFN), but not by antibodies to human IL-1, tumor necrosis factor, or βIFN. Colony formation by highly purified CFU-E was also inhibited by recombinant human γIFN (rhγIFN). IL-1 and γIFN play significant roles in the pathogenesis of the anemia of chronic disease. These studies indicate that rhIL-1 inhibits CFU-E colony formation by an indirect mechanism involving T-lymphocytes and requiring γIFN and that γIFN itself is most probably the direct mediator of this effect.Keywords
This publication has 22 references indexed in Scilit:
- Different haematopoietic growth factors have different capacity in overcoming the in vitro interferon gamma-induced suppression of bone marrow progenitor cellsEuropean Journal of Haematology, 2009
- Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells.Journal of Clinical Investigation, 1990
- Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.Journal of Clinical Investigation, 1989
- Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.Annals of the Rheumatic Diseases, 1988
- Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation.Journal of Clinical Investigation, 1988
- Inhibition by interleukin‐1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemiasBritish Journal of Haematology, 1987
- Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin.Journal of Clinical Investigation, 1987
- Immunological aspects of the anemia of rheumatoid arthritisAmerican Journal of Hematology, 1987
- Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.Journal of Clinical Investigation, 1985
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979